StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)

Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –

Ironwood Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Ironwood Pharmaceuticals's total debt was $120.70M at Mar 31, 2022. For fiscal 2018 it was $100.54M, down 31.6% from the year before. The highest annual figure on record is $174.67M in fiscal 2013.

Annual total debt

PeriodPeriod endValueChange
FY2018Dec 31, 2018$100.54M-31.6%
FY2017Dec 31, 2017$146.90M+11.1%
FY2016Dec 31, 2016$132.25M-0.5%
FY2015Dec 31, 2015$132.96M-15.9%
FY2014Dec 31, 2014$158.15M-9.5%
FY2013Dec 31, 2013$174.67M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2022Mar 31, 2022$120.70M+33.9%
Q3 FY2021Sep 30, 2021$120.70M+20.1%
Q2 FY2021Jun 30, 2021$120.70M+11.2%
Q2 FY2019Jun 30, 2019$78.33M-36.1%
Q1 FY2019Mar 31, 2019$90.14M-33.3%
Q4 FY2018Dec 31, 2018$100.54M-31.6%
Q3 FY2018Sep 30, 2018$108.59M-17.9%
Q2 FY2018Jun 30, 2018$122.61M-7.1%
Q1 FY2018Mar 31, 2018$135.22M–
Q4 FY2017Dec 31, 2017$146.90M–
Q4 FY2016Dec 31, 2016$132.25M–
Q3 FY2016Sep 30, 2016$131.94M–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?